1-2 of 2
Muriel Busson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth

Philippe Blache, Lucile Canterel-Thouennon, Muriel Busson, Pascal Verdié, Gilles Subra, Marc Ychou, Corinne Prévostel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (8): 1386–1395.
https://doi.org/10.1158/1535-7163.MCT-18-1149
Published: 01 August 2019
View article titled, A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth
Open the PDF for A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth in another window
Includes: Supplementary data
Journal Articles

Abstract B245: Claudin-1 (CLDN1) as a new therapeutic target in colorectal cancer: Inhibition of cell growth and survival by an anti-CLDN1 monoclonal antibody.

Adeline Ayrolles-Torro, Nadia Vezzio-Vie, Vincent Denis, Florence Boissiere-Michot, Véronique Garambois, Muriel Busson, Imade Ait Arsa, Caroline Mollevi, Martine Pugniere, Frédéric Bibeau, Pierre Martineau, Céline Gongora, Maguy Del Rio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B245.
https://doi.org/10.1158/1535-7163.TARG-13-B245
Published: 01 November 2013
View article titled, Abstract B245: Claudin-1 (CLDN1) as a new therapeutic target in colorectal cancer: Inhibition of cell growth and survival by an anti-CLDN1 monoclonal antibody.